Ambiq Micro, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.39. Operator: Good morning, and welcome to the Ambiq Micro, Inc. Fourth Quarter and Full Year 2025 Earnings ...
In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% of patients achieving ASAS40 by Week 12 Consistently, ...
Here’s what you can look forward to on the day! From the moment you arrive, we’ll make sure your Applicant Event is packed with exciting experiences and opportunities to connect with your future at ...
Update: Since this first drive was originally published in July, 2025, we finished testing the Audi Q5. Read the complete Audi Q5 road test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results